Octopus Discloses 15.36% IDOX Stake and Vanguard Reports 5.71% in Avadel Under Rule 8.3

Overview

• Octopus Investments reported ownership of 70,924,725 IDOX plc shares, equal to 15.36%, with the position dated 24 November 2025 and disclosed on 25 November 2025.
• Octopus recorded a sale of 34,486 IDOX ordinary shares at a unit price of 0.698116, as shown in the same filing.
• The Vanguard Group disclosed 5,565,939 Avadel Pharmaceuticals plc shares, representing 5.71%, with the position dated 21 November 2025 and disclosed on 24 November 2025.
• Vanguard’s filing noted a purchase of 958 Avadel shares at $23.03 per share and stated no indemnities, options arrangements, or concert-party understandings.
• A separate Form 8.3 from State Street Global Advisors & Affiliates showed a 2.33554% long position in Avadel and reported same-day buys and sales on 24 November 2025 at $22.92 per share.